Company intelligence

xCures

Last verified Jun 24, 2026

Key Metrics

Valuation
$127 million
As of Jun 24, 2026Derivedcitybiz

Recent changes

  1. Jun 24, 2026Raised $46M Series B at a $127 million valuation citybiz
  2. Jun 24, 2026First reported valuation: $127 million citybiz
  3. Jun 24, 2026New investor: Innovius Capital citybiz
  4. Jun 24, 2026xCures Raises $46M Series B to Turn Messy Medical Records Into Clean Clinical Data With AI Pulse story

Funding History

1 event · sources dated per row
DateEventAmountValuationInvestorsSource
Jun 24, 2026Series B$46M$127 million
Innovius CapitalLeadunverifiedSpring Mountain Capital
Pulse story

Investors

Latest Pulse

  1. xCures Raises $46M Series B to Turn Messy Medical Records Into Clean Clinical Data With AIxCures landed a $46 million Series B led by Innovius Capital to scale its AI platform that converts fragmented patient records into structured, decision-ready clinical data. The round more than doubled its valuation to $127 million post-money, on the back of ARR that tripled to ~$10M in 2025 and a cash-flow-breakeven business.→

Coverage Timeline

newest first
  1. Jun 24, 2026FUNDINGxCures Raises $46M Series B to Turn Messy Medical Records Into Clean Clinical Data With AI$46M→

All Coverage

xCures FAQ

What is xCures's valuation?

xCures's valuation is $127 million (As of Jun 24, 2026, citybiz).

Who are xCures's investors?

xCures's investors include Innovius Capital, Civilization Ventures (As of Jun 24, 2026).

Sources & methodologyshow
Where these figures come from

Figures are labelled Reported (a source states it), Estimated, Derived (computed from other facts) or Rumored (in talks / unconfirmed). Rumors never replace a confirmed figure. Each figure keeps its own as-of date; history is preserved rather than overwritten.

How we verify data · Suggest a correction